Welcome to Durian Pharmaceuticals.
- durianpharmaceuticals@gmail.com
Showing all 6 results
NSOZ Junior is a paediatric-friendly formulation of Esomeprazole, a proton pump inhibitor (PPI), specially designed as delayed-release granules for oral suspension. It provides targeted relief from acid-related disorders in children by suppressing gastric acid secretion and promoting mucosal healing. Ideal for use in GERD, erosive esophagitis, and acid-related dyspepsia in paediatric patients.
NSOZ-D is a synergistic combination of Esomeprazole Magnesium (a proton pump inhibitor) and Domperidone (a prokinetic agent), designed to provide fast and sustained relief from acid reflux, gastroesophageal reflux disease (GERD), dyspepsia, and related upper GI disorders. The dual-release capsule ensures optimal timing of both acid suppression and improved gastric motility.
Ruby-LSR combines the potent acid-suppressing action of Rabeprazole Sodium (Enteric-Coated) with the prokinetic benefits of Levosulpiride (Sustained Release). This synergistic formula is designed to provide fast and lasting relief from acid reflux, gastritis, GERD, and functional dyspepsia by controlling gastric acid secretion and improving gastrointestinal motility.
Sheer-O suspension is indicated for the treatment of various gastrointestinal conditions, including gastric ulcers, duodenal ulcers, gastritis, esophagitis, and gastroesophageal reflux disease (GERD). It is particularly beneficial for patients experiencing discomfort, pain, and irritation associated with these conditions.
URSOGUD 300 contains Ursodeoxycholic Acid (UDCA) 300 mg, a naturally occurring bile acid that supports liver health and aids in the dissolution of cholesterol-rich gallstones. It improves bile flow, protects liver cells from damage, and is especially beneficial in treating cholestatic liver diseases, primary biliary cholangitis, and non-alcoholic fatty liver disease (NAFLD). URSOGUD 300 helps normalize liver enzyme levels and delays progression of liver dysfunction.